Search Results - "Naylor, Paul H."

S1177 Assessment of Mucosal Healing in a Predominantly African American General Gastroenterology Clinic by Hanna, Angy, Kim, Paul, Wang, Jing, Bathla, Jasdeep, Mohamad, Bashar, Naylor, Paul H., Mutchnick, Milton G.

“…Methods: Using the ICD-10 code for CD and medical record review, 136 patients with at least 1 GI evaluation were identified. Endoscopic evaluation at earliest…”
Get full text

S1450 Bias-Influenced Misdiagnosis of NAFLD in the African American Community by Saini, Astha, Damughatla, Anirudh R., Naylor, Paul H., Mutchnick, Milton G.

“…Accurate diagnosis is mandatory as advanced fibrosis (NASH) is a predictor of liver-related mortality and requires close monitoring. During our data analysis,…”
Get full text

S1126 Racial and Socioeconomic Diversity and Impediments to Care of Crohn’s Disease Patients at an Urban Medical Center by Kim, Paul, Hanna, Angy, Wang, Jing, Mohamad, Bashar, Naylor, Paul H., Mutchnick, Milton G.

“…When subjected to multivariate nominal logistic analysis, race remained the dominant significant factor in compliance (last column in Table 1). With respect to…”
Get full text

S1072 Ulcerative Colitis in Patients Seen in a Predominantly African American Urban Health Center by Khadra, Majd, Majagi, Anusha, Chaer, Kenan Abou, Karne, Saumya L., Mohamad, Bashar, Naylor, Paul H., Mutchnick, Milton G.

Get full text

S1710 Evolving Patterns of Cirrhosis Etiology in the Era of Direct-Acting Antivirals on in a Predominately African American Population by Alnasarat, Ahmad, Minos, Alexander N., Khamis, Rana, Khadra, Majd, Naylor, Paul H., Mutchnick, Milton G.

Get full text

S1324 Racial Disparity for IBD Manifestation and Treatment in an Urban General GI Clinic Population by Chaer, Kenan Abou, Khadra, Majd, Majagi, Anusha, Karne, Saumya L., Zhang, Minie, Hanna, Angy, Mohamad, Bashar, Naylor, Paul H., Mutchnick, Milton G.

Get full text

S1490 Racial Differences in Cirrhosis Etiology and Manifestation in a Predominately African American Urban Medical Center by Mohiuddin, Aabid, Bathla, Jasdeep, Alnasarat, Ahmad, Saini, Astha, Damughatla, Anirudh R., Almujarkesh, Mohamad Khaled, Milan-Ortiz, Vanessa, Tepe, GokTurk, Naylor, Paul H., Mutchnick, Milton G., Kim, Paul

“…[...]of viral elimination in HCV individuals, they did not develop decompensation compared to HCV non-treated and other etiologies. Based on these…”
Get full text

476 Diagnostic Yield of EUS in Identifying Metastasis to Adrenals in Patients With Known or Suspected Lung Cancer: A Meta-Analysis by Patel, Suhag, Naylor, Paul H, Jinjuvadia, Kartikkumar, Anees, Mohammad

Get full text

Su1405 Setting and Documentation of Hepatitis C Virus Antibody Testing in a Veteran Population: Does It Impact RNA Confirmation Testing? by Judd, Stephanie, Liubakka, Alyssa, Patel, Suhag, Pavle, Alexis, Naylor, Paul H, Antaki, Fadi

Get full text

Poor Effectiveness of Ultrasound Surveillance Prior to Diagnosis of HCC in a Predominately African American Population by Rutledge, Brian, Sahni, Neha, Naylor, Paul H, Benjaram, Sindhuri, Hussain, Zara, Philip, Philip, Ehrinpreis, Murray N, Mutchnick, Milton G

Get full text

Performance characteristics of EUS-FNA biopsy for adrenal lesions: A meta-analysis by Patel, Suhag, Jinjuvadia, Raxitkumar, Devara, Anupama, Naylor, Paul, Anees, Mohammad, Jinjuvadia, Kartikkumar, Al-Haddad, Mohammad

“…Background and Objective: The role of EUS-FNA biopsy (EUS-FNAB) for detection of metastatic lesions (mets) to adrenals has not been evaluated systematically…”
Get full text

Tu1062 Long Term Mortality and Morbidity in African Americans With Hepatitis C by Stubbs, Aaron, Naylor, Paul H, Ravindran, Karthik, Benjaram, Sindhuri, Reddy, Naveen G, May, Elizabeth, Ehrinpreis, Murray, Mutchnick, Milton G

Get full text

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells by Da Silva, Diane M, Woodham, Andrew W, Naylor, Paul H, Egan, James E, Berinstein, Neil L, Kast, W Martin

“…Langerhans cells (LCs) are the antigen-presenting cells of the epithelial layer and are responsible for initiating immune responses against skin and…”
Get more information

Decreasing racial disparity with the combination of ledipasvir-sofosbuvir for the treatment of chronic hepatitis C by Naylor, Paul H, Mutchnick, Milton

“…African Americans (AA) in the US are twice as likely to be infected with hepatitis C virus (HCV) compared to the non-Hispanic-white US population (Cau). They…”
Get full text

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen by Berinstein, Neil L., Wolf, Gregory T., Naylor, Paul H., Baltzer, Lorraine, Egan, James E., Brandwein, Harvey J., Whiteside, Theresa L., Goldstein, Lynn C., El-Naggar, Adel, Badoual, Cecile, Fridman, Wolf-Herve, White, J. Michael, Hadden, John W.

“…Twenty-seven subjects with squamous cell cancer of the head and neck received the neoadjuvant IRX-2 immunotherapy regimen prior to surgery in a Phase 2 trial…”
Get full text

Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population by Kundumadam, Shanker, Naseer, Maliha, Kaloti, Zaid, Kiwan, Wissam, Kathi, Pradeep R, Nas, Hala, Naylor, Paul H, Al-Subee, Omar

“…Screening colonoscopy aims to interrupt the adenoma-carcinoma sequence by removing all precancerous adenomatous polyps. Adenomatous polyp detection rate (ADR)…”
Get full text

Preclinical studies with IRX-2 and thymosin alpha 1 in combination therapy by Naylor, Paul H, Hadden, John W

“…Thymosin alpha 1 (T alpha 1) is a 28 amino acid biologically active protein with pleiotropic immune enhancing activity. IRX-2 is a primary cell-derived…”
Get full text

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma by Whiteside, Theresa L., Butterfield, Lisa H., Naylor, Paul H., Egan, James E., Hadden, John W., Baltzer, Lorraine, Wolf, Gregory T., Berinstein, Neil L.

“…Objective IRX-2, a primary cell-derived biologic with pleotropic immune activity, was shown to induce increased lymphocyte infiltrations into the tumor of…”
Get full text

Immunopharmacology of Thymosin alpha 1 and Cytokine Synergy by Naylor, Paul H, Quadrini, Karen, GARACI, ENRICO, Rasi, Guido, Hadden, John W

“…AbstractThymosin alpha 1 (T alpha 1) is a 28 amino acid biologically active protein cleaved from positions 2-29 of a precursor protein, prothymosin alpha …”
Get full text

Peptide Based Vaccine Approaches for Cancer-A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen by Naylor, Paul H, Egan, James E, Berinstein, Neil L

“…Therapeutic cancer vaccines have the potential to generate a long lasting immune response that will destroy tumor cells with specificity and safety, in…”
Get full text